Panel looks to apply COVID-19 lessons to flu preparedness
The National Academy of Medicine has named an international committee to assess how COVID-19 vaccine development and other policies could facilitate global efforts to prepare for seasonal flu and a flu pandemic.
As part of the initiative, the Department of Health and Human Services has asked the National Academies of Sciences, Engineering, and Medicine to release consensus reports this fall on vaccine research and development; vaccine distribution and supply chains; public health interventions and countermeasures; and global coordination, partnerships and financing.
NAM will host a public workshop this spring to hear from experts and gather feedback to inform the reports.
Related News Articles
Headline
The Centers for Disease Control and Prevention will update its immunization schedules for the COVID-19 and chickenpox vaccines to adopt recent recommendations…
Headline
AHA’s latest social media toolkit for spreading awareness of the flu focuses on the availability of the flu vaccine for at-risk, vulnerable populations as flu…
Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The flu hospitalization rate during the 2024-25 flu season was the highest since 2010-11, according to a report published Sept. 12 by the Centers for Disease…